NCT05377736

Brief Summary

This pilot study aims at describing the prevalence and distribution of molecular alterations in thyroid nodules of benign and malignant origin at the level of DNA and RNA in a Danish population. Patients with thyroid nodules suspected of malignancy is included prospectively. Tissue samples are collected for molecular analyses form surgical specimens and bloodsamples, and preoperative clincial features are registered.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Mar 2022Jan 2027

Study Start

First participant enrolled

March 1, 2022

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

March 15, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 17, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 18, 2027

Expected
Last Updated

January 6, 2025

Status Verified

January 1, 2025

Enrollment Period

3.5 years

First QC Date

March 15, 2022

Last Update Submit

January 3, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • DNA alterations

    Whole genome sequencing by next generation sequencing

    Two years

  • RNA alterations

    Total RNA sequencing including circular RNA, micro RNA and messenger RNA

    Two years

  • DNA methylation

    Whole Genome Bisulfite Sequencing

    Two years

  • Circulating tumor DNA

    Whole genome sequencing of leucocyt DNA and circularing DNA

    Two years

Study Arms (1)

Molecular testing

EXPERIMENTAL

Descriptive and explorative study including identical molecular analyses applied to all included patients

Genetic: Molecular analyses

Interventions

Collect thyroid tissue for molecular analysis from the histological specimen collected by routine surgery

Molecular testing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Thyroid nodule \>1.5 cm
  • BSRTC: IV, V, og VI

You may not qualify if:

  • No surgical specimen available
  • Purely cystic nodules

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus Universityhospital

Aarhus N, 8200, Denmark

Location

MeSH Terms

Conditions

Thyroid NoduleDiseaseThyroid Neoplasms

Interventions

Molecular Docking Simulation

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Models, MolecularModels, TheoreticalInvestigative Techniques

Study Officials

  • Kristine Z Swan

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 15, 2022

First Posted

May 17, 2022

Study Start

March 1, 2022

Primary Completion

August 31, 2025

Study Completion (Estimated)

January 18, 2027

Last Updated

January 6, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

IPD will be in accordance with Danish legislation and regulations within the area

Locations